Skip to content
All-In PodcastAll-In Podcast

E46: False Ivermectin narratives, regulatory grift, wartime mentality in solving issues & more

Show Notes: 0:00 Open: LIVE from TPB Symposium 1:18 False Ivermectin story fools Rolling Stone, Rachel Maddow & more 15:47 Biden's recently announced vaccine mandates, why US hasn't been able to solve cheap testing 25:36 The threat of regulatory capture 34:18 Benefits of the "wartime mentality" when solving major issues 45:30 CCP looking to break up Alipay, what this means for US/China relations 49:11 Audience Q&A! Follow the besties: https://twitter.com/chamath https://linktr.ee/calacanis https://twitter.com/DavidSacks https://twitter.com/friedberg Follow the pod: https://twitter.com/theallinpod https://linktr.ee/allinpodcast Intro Music Credit: https://rb.gy/tppkzl https://twitter.com/yung_spielburg Intro Video Credit: https://twitter.com/TheZachEffect Referenced in the show: https://kfor.com/news/local/patients-overdosing-on-ivermectin-backing-up-rural-oklahoma-hospitals-ambulances/ https://www.rollingstone.com/politics/politics-news/gunshot-victims-horse-dewormer-ivermectin-oklahoma-hospitals-covid-1220608/ https://twitter.com/RollingStone/status/1433922442850930696 https://twitter.com/maddow/status/1433521336282976256 https://twitter.com/ggreenwald/status/1434854957614780424 https://www.wsj.com/articles/facebook-files-xcheck-zuckerberg-elite-rules-11631541353 https://www.ft.com/content/01b7c7ca-71ad-4baa-bddf-a4d5e65c5d79 https://sacks.substack.com/p/your-startup-is-a-movement https://twitter.com/DavidSacks/status/1426986193271640065 #allin #tech #news

David FriedberghostJason CalacanishostChamath PalihapitiyahostAudience memberguestAlex Filippenkoguest
Sep 14, 20211h 12mWatch on YouTube ↗

CHAPTERS

  1. 0:00 – 1:17

    Live at the Production Board Symposium: banter, setup, and why this event exists

    The episode opens live on stage with the hosts teasing each other, then quickly establishes the context: the Production Board Symposium and its mix of scientists, engineers, investors, and operators. Friedberg explains the intent of convening this group and jokingly frames hosting the All-In podcast as a way to “chase half of you away.”

    • On-stage roast/banter sets a casual live-event tone
    • Jason tees up what the Production Board Symposium represents
    • Friedberg describes the attendee mix: science, academia, business, investing
    • Positioning: sharing ideas over the next couple of days with a systems mindset
  2. 1:17 – 2:34

    Rolling Stone’s ivermectin story: how a narrative outran verification

    The group breaks down the viral ivermectin ER-overrun story and why it collapsed under basic scrutiny. They argue the media amplified an emotionally satisfying narrative without checking sources or plausibility, then highlight how corrections and accountability often lag behind the original outrage.

    • Recap of KFOR and Rolling Stone claims about ivermectin overdoses
    • Misleading photo use and the story’s later refutation
    • Incentives: outrage, clicks, and “moral mania” driving coverage
    • Claimed double standard: low consequences for prominent amplifiers
  3. 2:34 – 9:17

    What we actually know about ivermectin—and why the debate gets distorted

    Chamath pivots from the media angle to the scientific uncertainty: ivermectin has multiple biological interactions, but the evidence base for COVID efficacy remains contested without broad, rigorous trials. The group argues both proponents and opponents often speak beyond the data, while public discourse reduces it to “horse dewormer” caricatures.

    • Ivermectin’s mechanisms discussed at a high level; uncertainty emphasized
    • Need for large, double-blind studies to resolve efficacy questions
    • Critique of simplistic framing (e.g., “horse paste”)
    • Science communication breaks when uncertainty becomes tribal
  4. 9:17 – 13:31

    Platform moderation and 'Crosscheck': unequal rules, censorship, and trust erosion

    The conversation expands into content moderation and accusations of preferential treatment on social platforms. They reference reporting about Facebook’s 'crosscheck' and argue perceived two-tier enforcement undermines trust and inflames polarization.

    • Claims that prominent accounts face fewer moderation consequences
    • Discussion of Facebook 'crosscheck' as an override mechanism
    • Broader concern: who decides what’s true and what gets suppressed
    • Prediction that these dynamics intensify polarization rather than reduce it
  5. 13:31 – 15:45

    Escaping echo chambers: information diets, audience poll, and the media-bias feedback loop

    They advise varying one’s “information diet” to avoid hoaxes and reflexive narratives, then interact with the live audience via polls about tech bias and voting. The segment underscores how fragmented media consumption and confirmation bias can produce extreme, self-reinforcing views.

    • Advice: diversify sources to avoid ideological capture
    • Live audience poll suggests broad agreement on tech platform bias
    • Echo chambers blamed for demonizing the other side
    • Fragmentation + emotion-driven consumption accelerates misinformation loops
  6. 15:45 – 21:58

    Vaccine mandates and the missing piece: cheap, ubiquitous rapid testing

    The hosts debate vaccine mandates across government and private employers, focusing on practicality and legitimacy. Sacks emphasizes operational challenges (testing cadence, cost, documentation), while the group laments the U.S. failure to deliver low-cost rapid tests that could make policies more workable.

    • Distinction between employer choice vs federal mandate concerns
    • Operational reality: workforce walkouts and testing logistics
    • Rapid, cheap testing framed as a crucial but unmet infrastructure need
    • Variant risk raised as a justification for stronger interventions
  7. 21:58 – 25:41

    Testing as 'regulatory grift': FDA barriers, procurement incentives, and the wartime alternative

    Friedberg argues the U.S. testing market was constructed to favor incumbents and expensive procurement rather than mass manufacturing. They describe how a 'wartime' approach could have produced billions of paper-based tests cheaply, but regulatory and purchasing structures instead drove taxpayer-funded payouts.

    • Contrast: Germany’s cheaper tests vs U.S. pricing and availability
    • Critique of procurement: government subsidizing retail distribution
    • Claim: mass test production is technically feasible quickly
    • FDA approval process and incentives framed as structural blockers
  8. 25:41 – 29:32

    Regulatory capture in healthcare and climate policy: administrators, Obamacare incentives, and EV credits

    The conversation widens to regulatory capture as a systemic problem, citing growth in healthcare administration and perverse incentives. Chamath points to EV tax credits favoring unionized manufacturers (excluding Tesla) and climate incentives that reward lobbying strength over breakthrough impact.

    • Healthcare admin growth cited as symptom of bureaucratic bloat
    • Argument that margin caps can drive price inflation incentives
    • Tesla/union-linked EV credits framed as political favoritism
    • Climate dollars said to flow to incumbents and installers vs deep-tech solutions
  9. 29:32 – 34:18

    Breakthrough energy vs regulation: fusion progress, nuclear constraints, and 'cataclysm needed' pessimism

    They discuss the promise of advanced nuclear and fusion, referencing recent magnet breakthroughs and the perpetual 'five years away' trope. The hosts argue technical progress is real, but permitting and regulatory friction make deployment slow—possibly requiring a crisis to shift public tolerance.

    • Fusion update: superconducting magnet progress and tokamak control
    • Small nuclear reactors discussed as promising but heavily burdened
    • Regulatory timelines seen as bigger bottleneck than science
    • Provocative view: only a major crisis may unlock nuclear adoption
  10. 34:18 – 41:07

    Wartime mentality beyond COVID: climate infrastructure, ROI thinking, and skepticism about government effectiveness

    Audience questions steer the panel toward whether the U.S. should adopt a wartime posture on climate and other existential risks. Friedberg argues private markets are innovating, but large-scale infrastructure requires coordinated public investment—yet current bills often become giveaways rather than problem-solving spend.

    • Case for wartime framing: prioritize outcomes over politics
    • Private capital is flowing, but infrastructure needs public dollars
    • Critique: spending without measurable results or 10x/100x impact
    • Debate: corruption vs systemic incentive failures in governance
  11. 41:07 – 45:29

    Entrepreneurship vs Washington: Afghanistan as a spending-efficiency comparison

    Sacks contrasts $2T spent in Afghanistan with roughly comparable total VC investment over two decades, arguing private innovation yielded far more societal value. The point reinforces their belief that decentralized entrepreneurial systems produce better ROI than large federal programs—while warning policy could still stifle innovation.

    • Afghanistan framed as massive spend with poor outcomes
    • VC’s cumulative spend compared to government’s $2T war costs
    • Claim: startups created enormous value with far less capital waste
    • Concern about tax policy and regulation dampening innovation
  12. 45:29 – 49:15

    China tightens control: Alipay breakup, data sovereignty, Taiwan risk, and U.S. strategic gaps

    Friedberg introduces China’s move against Alipay; Chamath and Sacks interpret it as CCP consolidation of power and, crucially, data. The discussion links China’s industrial strategy to semiconductor dependence, Taiwan’s geopolitical flashpoint, and the paradox of U.S. openness to apps like TikTok.

    • CCP action framed as vertical integration of state + private sector
    • Data control highlighted as a central motive (credit + consumer data)
    • Taiwan/TSMC dependence described as a U.S. vulnerability
    • Argument: China’s actions are logical; U.S. lack of response is not
  13. 49:15 – 1:12:58

    Audience Q&A: fixing governance incentives, finding shared truth, and All-In’s responsibility to act

    The final segment is wide-ranging Q&A: critiques about not reading bills, debate over media bias roots, and ideas to attract smarter talent into government (compensation, prestige, engagement). It closes with a challenge for All-In to evolve from commentary into a strategic civic plan, with the hosts admitting they’re still figuring out how to operationalize their influence.

    • Transparency: reliance on summaries; legislation seen as illegible
    • Media bias debate and how fragmentation drives partisanship
    • Ideas for better government: incentives, pay, prestige, engagement
    • Call for All-In to produce a strategic plan; hosts acknowledge internal limits and next steps

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.